Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan and Amlodipine vs Amlodipine in Primary Hypertension
CTR20232888Phase 3Completed
- Sponsor
- Beijing Baiao Pharmaceuticals
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irbesartan + amlodipine in hypertension (HTN), sponsored by Beijing Baiao Pharmaceuticals. Started Oct 2023; status: completed.
02
Drugs
irbesartan + amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on CTR20232888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232888.